Group One Trading
ATHE

Group One Trading’s Alterity Therapeutics ATHE Stock Holding History

Group One Trading’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4
Closed – – 4805
2017
Q4 		$0 Sell
4
-50
-93% -$1.57K ﹤0.01% 4816
2017
Q3 		$2K Hold
54
– – ﹤0.01% 4630
2017
Q2 		$1K Hold
54
– – ﹤0.01% 4623
2017
Q1 		$2K Hold
54
– – ﹤0.01% 4434
2016
Q4 		$1K Hold
54
– – ﹤0.01% 4298
2016
Q3 		$2K Hold
54
– – ﹤0.01% 4356
2016
Q2 		$3K Sell
54
-53
-50% -$2.04K ﹤0.01% 4362
2016
Q1 		$3K Buy
107
+56
+110% +$1.87K ﹤0.01% 4295
2015
Q4 		$2K Buy
+51
New +$2.59K ﹤0.01% 4519
2015
Q2 		– Sell
-534
Closed -$40.1K – 4834
2015
Q1 		$36K Buy
534
+233
+77% +$18.6K ﹤0.01% 3549
2014
Q4 		$30K Buy
+301
New +$32.5K ﹤0.01% 3722
2014
Q3 		– Sell
-971
Closed -$130K – 5109
2014
Q2 		$132K Sell
971
-261
-21% -$29.8K ﹤0.01% 2747
2014
Q1 		$207K Buy
1,232
+1,190
+2,833% +$657K ﹤0.01% 2413
2013
Q4 		$18K Sell
42
-65
-61% -$19.4K ﹤0.01% 4291
2013
Q3 		$26K Buy
+107
New +$24.6K ﹤0.01% 4004

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Group One Trading's ATHE Position: Q1 2018 in Review

Group One Trading sold out of Alterity Therapeutics (ATHE) in Q1 2018, closing a stake of 4 shares.

Group One Trading first reported a position in ATHE in Q3 2013 and held it in 15 quarters. The position peaked at $207K in Q1 2014. 12 funds tracked by Wall St. Rank hold ATHE as of Q1 2018.

  • Group One Trading reported no remaining Alterity Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Group One Trading sold 4 Alterity Therapeutics shares in Q1 2018.
  • Group One Trading first reported a position in Alterity Therapeutics in Q3 2013 and held it in 15 quarters.
  • Group One Trading's Alterity Therapeutics position peaked at $207K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.